Population-based HIV Impact Assessments in Resource-Constrained Settings under the President?s Emergency Plan for AIDS Relief (PEPFAR)

Post Date

March 20th 2014

Application Due Date

May 5th 2014

Funding Opportunity Number

CDC-RFA-GH14-1409

CFDA Number(s)

93.067

Funding Instrument Type(s)

Cooperative Agreement

Funding Activity Categories

Health

Number of Awards

2

Eligibility Categories

Other

Eligible Applicants Eligible applicants that can apply for this funding opportunity are listed below: ╔ Nonprofit with 501C3 IRS status (other than institution of higher education) ╔ Nonprofit without 501C3 IRS status (other than institution of higher education) ╔ For-profit organizations (other than small business) ╔ Small, minority, and women-owned businesses ╔ Universities ╔ Colleges ╔ Research institutions ╔ Hospitals ╔ Community-based organizations ╔ Faith-based organizations ╔ Federally recognized or state-recognized American Indian/Alaska Native tribal governments ╔ American Indian/Alaska native tribally designated organizations ╔ Alaska Native health corporations ╔ Urban Indian health organizations ╔ Tribal epidemiology centers ╔ State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau) ╔ Political subdivisions of States (in consultation with States) ╔ Non-domestic (non-U.S.) entity

Funding

• Estimated Total Funding:

  $125000000

• Award Range:

  $0 - $25000000

Grant Description

╔ Achieving primary prevention of HIV infection through activities such as expanding confidential counseling and testing programs linked with evidence based behavioral change and building programs to reduce mother-to-child transmission; ╔ Improving the care and treatment of HIV/AIDS, sexually transmitted infections (STIs) and related opportunistic infections by improving STI management; enhancing laboratory diagnostic capacity and the care and treatment of opportunistic infections; interventions for intercurrent diseases impacting HIV infected patients including tuberculosis (TB); and initiating programs to provide anti-retroviral therapy (ART); ╔ Strengthening the capacity of countries to collect and use surveillance data and manage national HIV/AIDS programs by expanding HIV/STI/TB surveillance programs and strengthening laboratory support for surveillance, diagnosis, treatment, disease monitoring and HIV screening for blood safety; and ╔ Developing, validating and/or evaluating public health programs to inform, improve and target appropriate interventions, as related to the prevention, care and treatment of HIV/AIDS, TB and opportunistic infections.

Contact Information

• Agency

  Department of Health and Human Services

• Office:

  Centers for Disease Control and Prevention

• Agency Contact:

  CDC
  Procurement and Grants Office
  Technical Informaiton Management Section
  Phone 770-488-2700

• Agency Mailing Address:

  PGOTIM

• Agency Email Address:

  pgotim@cdc.gov